Back
KLBF - Kalbe Farma

KLBF - Net profit grew 10.97% yoy in 9M25

28 October 2025

KLBF - Net profit grew 10.97% yoy in 9M25 Kalbe Farma (KLBF) booked a net profit of IDR2.63 tn in 9M25, up 10.97% yoy, supported by solid growth across its key business segments. Revenue rose 7.22% yoy to IDR25.98 tn, driven by higher sales in prescription drugs (+11.03%), health products (+9.45%), and distribution & logistics (+10.41%). The nutrition segment remained weak, declining 2.1% yoy to IDR6.04 tn, prompting management to revise its FY25 revenue growth target to 6–8% from the previous 8–10%. Gross profit reached IDR10.55 tn, while total assets climbed to IDR30.10 tn, reflecting steady balance sheet expansion amid higher short-term liabilities. (Source : Bisnis Indonesia)

Related Research

Healthcare
KLBF - Further growth in ‘25F on better product mix and costs ma...
Andre Suntono 13 June 2025 See Detail
Consumer
KLBF - Perbaikan ekonomi topang performa bisnis di masa depan
Winny Rahardja 08 April 2022 See Detail
Consumer
KLBF - Stronger growth and margins expansion
Andre Suntono 12 July 2023 See Detail